The fact that U. lactuca only shows ACE2 inhibitory activity and no potential binding affinity toward anti-DM targets suggests that its chemical profile may differ significantly from other macroalgae or have specific compounds that target specific pathways. This evidence concerns the gene ACE2 and diabetes mellitus.